blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3728249

EP3728249 - 1H -PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS [Right-click to bookmark this link]
Former [2020/44]1H -PYRAZOLO[4,3-b ]PYRIDINES AS PDE1 INHIBITORS
[2021/32]
StatusNo opposition filed within time limit
Status updated on  13.01.2023
Database last updated on 12.11.2024
FormerThe patent has been granted
Status updated on  04.02.2022
FormerGrant of patent is intended
Status updated on  13.10.2021
FormerRequest for examination was made
Status updated on  21.09.2021
FormerGrant of patent is intended
Status updated on  12.08.2021
FormerRequest for examination was made
Status updated on  25.09.2020
FormerThe international publication has been made
Status updated on  29.06.2019
Formerunknown
Status updated on  15.01.2019
Most recent event   Tooltip27.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 30.10.2024  [2024/44]
Applicant(s)For all designated states
H. Lundbeck A/S
Ottiliavej 9
2500 Valby / DK
[2020/44]
Inventor(s)01 / JUHL, Karsten
c/o H. Lundbeck A/S Ottiliavej 9
2500 Valby / DK
02 / CLEMENTSON, Carl, Martin, Sebastian
c/o H. Lundbeck A/S Ottiliavej 9
2500 Valby / DK
03 / JESSING, Mikkel
c/o H. Lundbeck A/S Ottiliavej 9
2500 Valby / DK
04 / MARIGO, Mauro
c/o H. Lundbeck A/S Ottiliavej 9
2500 Valby / DK
05 / RASMUSSEN, Lars, Kyhn
c/o H. Lundbeck A/S Ottiliavej 9
2500 Valby / DK
06 / LANGGÅRD, Morten
c/o H. Lundbeck A/S Ottiliavej 9
2500 Valby / DK
07 / KEHLER, Jan
c/o H. Lundbeck A/S Ottiliavej 9
2500 Valby / DK
08 / VITAL, Paulo, Jorge, Vieira
c/o H. Lundbeck A/S Ottiliavej 9
2500 Valby / DK
 [2020/44]
Representative(s)H. Lundbeck A/S
Ottiliavej 9
2500 Valby / DK
[2020/44]
Application number, filing date18829349.219.12.2018
[2020/44]
WO2018EP85798
Priority number, dateDK2017PA0072720.12.2017         Original published format: DK PA201700727
DK2017PA0073020.12.2017         Original published format: DK PA201700730
[2020/44]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2019121885
Date:27.06.2019
Language:EN
[2019/26]
Type: A1 Application with search report 
No.:EP3728249
Date:28.10.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 27.06.2019 takes the place of the publication of the European patent application.
[2020/44]
Type: B1 Patent specification 
No.:EP3728249
Date:09.03.2022
Language:EN
[2022/10]
Search report(s)International search report - published on:EP27.06.2019
ClassificationIPC:C07D471/04, A61P25/28, A61K31/437, C07D519/00, A61P25/18, A61P25/22, A61P25/24
[2021/32]
CPC:
C07D471/04 (EP,US); A61P25/18 (EP,US); A61P25/22 (EP,US);
A61P25/24 (EP,US); A61P25/28 (EP,US); C07D519/00 (EP,US)
Former IPC [2020/44]C07D471/04, A61P25/28, A61K31/437, C07D519/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/44]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:H 1-PYRAZOLO[4,3-B]PYRIDINE ALS PDE1-INHIBITOREN[2020/44]
English:1H -PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS[2021/32]
French:1H -PYRAZOLO[4,3-B ]PYRIDINES UTILISÉ EN TANT QU'INHIBITEURS DE PDE1[2021/32]
Former [2020/44]1H -PYRAZOLO[4,3-b ]PYRIDINES AS PDE1 INHIBITORS
Former [2020/44]<SMALLCAPS/> H 1-PYRAZOLO[4,3- <NS2:I>B</NS2:I> ]PYRIDINES UTILIS& XC9;S EN TANT QU'INHIBITEURS DE PDE1
Entry into regional phase20.07.2020National basic fee paid 
20.07.2020Designation fee(s) paid 
20.07.2020Examination fee paid 
Examination procedure20.07.2020Examination requested  [2020/44]
20.07.2020Date on which the examining division has become responsible
14.01.2021Amendment by applicant (claims and/or description)
13.08.2021Communication of intention to grant the patent
09.09.2021Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
27.10.2021Communication of intention to grant the patent
28.01.2022Fee for grant paid
28.01.2022Fee for publishing/printing paid
28.01.2022Receipt of the translation of the claim(s)
Opposition(s)12.12.2022No opposition filed within time limit [2023/07]
Fees paidRenewal fee
11.01.2021Renewal fee patent year 03
03.01.2022Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU19.12.2018
AL09.03.2022
AT09.03.2022
CY09.03.2022
CZ09.03.2022
DK09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
MC09.03.2022
MK09.03.2022
MT09.03.2022
NL09.03.2022
PL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SI09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
IS09.07.2022
PT11.07.2022
[2024/44]
Former [2024/29]HU19.12.2018
AL09.03.2022
AT09.03.2022
CY09.03.2022
CZ09.03.2022
DK09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
MC09.03.2022
MK09.03.2022
NL09.03.2022
PL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SI09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
IS09.07.2022
PT11.07.2022
Former [2024/27]HU19.12.2018
AL09.03.2022
AT09.03.2022
CY09.03.2022
CZ09.03.2022
DK09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
MK09.03.2022
NL09.03.2022
PL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SI09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
IS09.07.2022
PT11.07.2022
Former [2024/24]HU19.12.2018
AL09.03.2022
AT09.03.2022
CY09.03.2022
CZ09.03.2022
DK09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
PL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SI09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
IS09.07.2022
PT11.07.2022
Former [2024/21]AL09.03.2022
AT09.03.2022
CY09.03.2022
CZ09.03.2022
DK09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
PL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SI09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
IS09.07.2022
PT11.07.2022
Former [2023/10]AL09.03.2022
AT09.03.2022
CZ09.03.2022
DK09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
PL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SI09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
IS09.07.2022
PT11.07.2022
Former [2023/07]AL09.03.2022
AT09.03.2022
CZ09.03.2022
DK09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
PL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
IS09.07.2022
PT11.07.2022
Former [2023/01]AL09.03.2022
AT09.03.2022
CZ09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
PL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
IS09.07.2022
PT11.07.2022
Former [2022/51]AT09.03.2022
CZ09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
PL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
IS09.07.2022
PT11.07.2022
Former [2022/50]AT09.03.2022
CZ09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
PL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
PT11.07.2022
Former [2022/49]AT09.03.2022
CZ09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SK09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
PT11.07.2022
Former [2022/48]AT09.03.2022
CZ09.03.2022
EE09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
PT11.07.2022
Former [2022/47]AT09.03.2022
FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
RO09.03.2022
RS09.03.2022
SE09.03.2022
SM09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
PT11.07.2022
Former [2022/44]FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
NL09.03.2022
RS09.03.2022
SE09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
Former [2022/39]FI09.03.2022
HR09.03.2022
LT09.03.2022
LV09.03.2022
RS09.03.2022
SE09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
Former [2022/36]HR09.03.2022
LT09.03.2022
LV09.03.2022
RS09.03.2022
SE09.03.2022
BG09.06.2022
NO09.06.2022
GR10.06.2022
Former [2022/35]HR09.03.2022
LT09.03.2022
RS09.03.2022
SE09.03.2022
BG09.06.2022
NO09.06.2022
Former [2022/33]LT09.03.2022
NO09.06.2022
Cited inInternational search[A]WO2016055618  (LUNDBECK & CO AS H [DK]) [A] 1-14* Whole document, specially abstract and claim 1 *;
 [IPA]WO2018007249  (H LUNDBECK AS [DK]) [IP] 1,3-6,8-14 * Whole document, specially claim 1 and examples * [A] 2,7
by applicantWO2008070095
 WO2013142307
    - SHARRON H. FRANCIS; MITSI A. BLOUNT; JACKIE D. CORBIN, Physiol Rev, (20110000), vol. 91, pages 651 - 690
    - AMY BERNARD et al., Neuron, (20120000), vol. 73, pages 1083 - 1099
    - BLOKLAND et al., Expert Opinion on Therapeutic Patents, (20120000), vol. 22, no. 4, pages 349 - 354
    - MEDINA, A. E., Frontiers in Neuropharmacology, vol. 5, page 21
    - Compendium of Organic Synthetic Methods, Wiley-Interscience, vol. I-XIII
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.